These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 27654337)

  • 1. A Multilaboratory, Multicountry Study To Determine Bedaquiline MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing.
    Kaniga K; Cirillo DM; Hoffner S; Ismail NA; Kaur D; Lounis N; Metchock B; Pfyffer GE; Venter A
    J Clin Microbiol; 2016 Dec; 54(12):2956-2962. PubMed ID: 27654337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Multilaboratory, Multicountry Study To Determine MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing of Selected First-Line Antituberculosis Drugs, Second-Line Injectables, Fluoroquinolones, Clofazimine, and Linezolid.
    Kaniga K; Cirillo DM; Hoffner S; Ismail NA; Kaur D; Lounis N; Metchock B; Pfyffer GE; Venter A
    J Clin Microbiol; 2016 Dec; 54(12):2963-2968. PubMed ID: 27654338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective
    Kaniga K; Hasan R; Jou R; Vasiliauskienė E; Chuchottaworn C; Ismail N; Metchock B; Miliauskas S; Viet Nhung N; Rodrigues C; Shin S; Simsek H; Smithtikarn S; Ngoc ALT; Boonyasopun J; Kazi M; Kim S; Kamolwat P; Musteikiene G; Sacopon CA; Tahseen S; Vasiliauskaitė L; Wu MH; Vally Omar S
    J Clin Microbiol; 2022 Jan; 60(1):e0291920. PubMed ID: 34705538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of Bedaquiline Phenotypic Drug Susceptibility Testing Methods and Breakpoints: a Multilaboratory, Multicountry Study.
    Kaniga K; Aono A; Borroni E; Cirillo DM; Desmaretz C; Hasan R; Joseph L; Mitarai S; Shakoor S; Torrea G; Ismail NA; Omar SV
    J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 31969421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bedaquiline susceptibility testing of Mycobacterium tuberculosis in an automated liquid culture system.
    Torrea G; Coeck N; Desmaretz C; Van De Parre T; Van Poucke T; Lounis N; de Jong BC; Rigouts L
    J Antimicrob Chemother; 2015 Aug; 70(8):2300-5. PubMed ID: 25977401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro culture conditions affecting minimal inhibitory concentration of bedaquiline against M. tuberculosis.
    Lounis N; Vranckx L; Gevers T; Kaniga K; Andries K
    Med Mal Infect; 2016 Jun; 46(4):220-5. PubMed ID: 27210281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentre testing of the EUCAST broth microdilution reference method for MIC determination on Mycobacterium tuberculosis.
    Schön T; Werngren J; Machado D; Borroni E; Wijkander M; Lina G; Mouton J; Matuschek E; Kahlmeter G; Giske C; Santin M; Cirillo DM; Viveiros M; Cambau E
    Clin Microbiol Infect; 2021 Feb; 27(2):288.e1-288.e4. PubMed ID: 33198949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of bedaquiline drug-susceptibility testing by BACTEC MGIT 960 system for
    Sivaramakrishnan G; Subramanyam B; Kumar MP; Golla R; Tripathy SP; Mondal R
    Int J Mycobacteriol; 2019; 8(4):329-332. PubMed ID: 31793501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multicenter evaluation of broth microdilution test, BrothMIC MTB, to determine minimum inhibitory concentrations (MICs) of antimicrobial agents for Mycobacterium tuberculosis--evaluation of interlaboratory precision and interpretive compatibility with agar proportion method].
    Yamane N; Ichiyama S; Kawahara S; Iinuma Y; Saitoh H; Shimojima M; Udagawa H; Nakasone I
    Rinsho Byori; 1999 Aug; 47(8):754-66. PubMed ID: 10511808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bedaquiline and linezolid MIC distributions and epidemiological cut-off values for Mycobacterium tuberculosis in the Latin American region.
    Lopez B; Siqueira de Oliveira R; Pinhata JMW; Chimara E; Pacheco Ascencio E; Puyén Guerra ZM; Wainmayer I; Simboli N; Del Granado M; Palomino JC; Ritacco V; Martin A
    J Antimicrob Chemother; 2019 Feb; 74(2):373-379. PubMed ID: 30358851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected high prevalence of resistance-associated Rv0678 variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline.
    Villellas C; Coeck N; Meehan CJ; Lounis N; de Jong B; Rigouts L; Andries K
    J Antimicrob Chemother; 2017 Mar; 72(3):684-690. PubMed ID: 28031270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced susceptibility and resistance to bedaquiline in clinical M. tuberculosis isolates.
    Peretokina IV; Krylova LY; Antonova OV; Kholina MS; Kulagina EV; Nosova EY; Safonova SG; Borisov SE; Zimenkov DV
    J Infect; 2020 May; 80(5):527-535. PubMed ID: 31981638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis.
    Rancoita PMV; Cugnata F; Gibertoni Cruz AL; Borroni E; Hoosdally SJ; Walker TM; Grazian C; Davies TJ; Peto TEA; Crook DW; Fowler PW; Cirillo DM;
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of MIC Quality Control Ranges for the Novel Gyrase Inhibitor Zoliflodacin.
    Miller AA; Traczewski MM; Huband MD; Bradford PA; Mueller JP
    J Clin Microbiol; 2019 Sep; 57(9):. PubMed ID: 31315953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multimethod, Multicountry Evaluation of Breakpoints for Bedaquiline Resistance Determination.
    Ismail NA; Aono A; Borroni E; Cirillo DM; Desmaretz C; Hasan R; Mitarai S; Shakoor S; Torrea G; Kaniga K; Omar SV
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32660992
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the broth microdilution plate methodology for susceptibility testing of Mycobacterium tuberculosis in Peru.
    Puyén ZM; Santos-Lázaro D; Vigo AN; Coronel J; Alarcón MJ; Cotrina VV; Moore DAJ
    BMC Infect Dis; 2022 Aug; 22(1):705. PubMed ID: 36002805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex isolates - the EUCAST broth microdilution reference method for MIC determination.
    Schön T; Werngren J; Machado D; Borroni E; Wijkander M; Lina G; Mouton J; Matuschek E; Kahlmeter G; Giske C; Santin M; Cirillo DM; Viveiros M; Cambau E
    Clin Microbiol Infect; 2020 Nov; 26(11):1488-1492. PubMed ID: 32750539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of MIC Distribution and Mechanisms of Decreased Susceptibility to Bedaquiline among Clinical Isolates of Mycobacterium abscessus.
    Li B; Ye M; Guo Q; Zhang Z; Yang S; Ma W; Yu F; Chu H
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium avium Complex.
    Brown-Elliott BA; Philley JV; Griffith DE; Thakkar F; Wallace RJ
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.